Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib maintenance in advanced colorectal cancer
2011-002384-16Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colorectal adenocarcinoma and metastatic colorectal adenocarcinoma (mCRC) comparing Axitinib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Started Sep 2011; status: completed.
02
Drugs
axitinib
03
Conditions
colorectal adenocarcinomametastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on 2011-002384-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002384-16.